What is H.C. Wainwright's price target for TERN?

H.C. Wainwright's latest stated price target for Terns Pharmaceuticals Inc. (TERN) is $20, from its action on Nov 4, 2025.

What is H.C. Wainwright's rating on TERN?

H.C. Wainwright rates TERN Neutral, a neutral rating, as of Mar 25, 2026.

When did H.C. Wainwright last change its view on TERN?

On Mar 25, 2026, H.C. Wainwright downgrades to Neutral from Buy.

Analyst firms · H.C. Wainwright · TERN

H.C. Wainwright TERN price target and rating history

Terns Pharmaceuticals Inc. (TERN) · Health Care

H.C. Wainwright rates Terns Pharmaceuticals Inc. (TERN) Neutral with a $20 price target, as of its latest action on Mar 25, 2026. It has published 4 rating actions on TERN since September 2022, including 1 upgrade and 1 downgrade.

Current rating: Neutral
Price target: $20
Median target, all firms: Too few
Actions on TERN: 4

H.C. Wainwright price target on TERN

H.C. Wainwright price target on TERN, each point a stated target, September 2022 to November 2025.

Every H.C. Wainwright rating on TERN

Mar 25, 2026
DowngradeH.C. Wainwright downgrades to Neutral from Buy
Nov 4, 2025
UpgradeH.C. Wainwright upgrades to Buy from Neutral, price target $20
Sep 4, 2025
ResumeH.C. Wainwright resumes coverage at Neutral
Sep 12, 2022
InitiateH.C. Wainwright starts coverage at Neutral, price target $6

How other firms rate TERN

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
H.C. Wainwright	Neutral		Mar 25, 2026
Leerink Partners	Outperform	$58	Feb 9, 2026

Questions about H.C. Wainwright and TERN

What is H.C. Wainwright's price target for TERN?: H.C. Wainwright's latest stated price target for Terns Pharmaceuticals Inc. (TERN) is $20, from its action on Nov 4, 2025.
What is H.C. Wainwright's rating on TERN?: H.C. Wainwright rates TERN Neutral, a neutral rating, as of Mar 25, 2026.
When did H.C. Wainwright last change its view on TERN?: On Mar 25, 2026, H.C. Wainwright downgrades to Neutral from Buy.

All H.C. Wainwright ratings TERN news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.